πŸ‡ΊπŸ‡Έ FDA
Patent

US 11485732

Compounds and uses thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 11485732 (Compounds and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P35/00, A61P35/02